{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:25:11Z","timestamp":1772807111589,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000801","name":"Bayer HealthCare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005974","name":"Population Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005974","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000801","name":"Bayer HealthCare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000801","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.contraception.2011.11.011","type":"journal-article","created":{"date-parts":[[2012,1,10]],"date-time":"2012-01-10T17:46:41Z","timestamp":1326217601000},"page":"96-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate\/dienogest"],"prefix":"10.1016","volume":"86","author":[{"given":"Ian S.","family":"Fraser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Schaefers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Mellinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Parke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Serrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2011.11.011_bb0005","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.contraception.2009.03.018","article-title":"Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate\/dienogest and ethinyl estradiol\/levonorgestrel","volume":"80","author":"Ahrendt","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.11.011_bb0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejogrb.2009.11.001","article-title":"Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate\/dienogest): a phase III trial","volume":"149","author":"Palacios","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.contraception.2011.11.011_bb0015","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3109\/00016346609158455","article-title":"Menstrual blood loss \u2014 a population study. Variation at different ages and attempts to define normality","volume":"45","author":"Hallberg","year":"1966","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2011.11.011_bb0020","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1093\/humrep\/der224","article-title":"Effective treatment of heavy and\/or prolonged menstrual bleeding with an oral contraceptive containing oestradiol valerate and dienogest: a randomised, double-blind phase III trial","volume":"26","author":"Fraser","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2011.11.011_bb0025","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/AOG.0b013e3182118ac3","article-title":"Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial","volume":"117","author":"Jensen","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.11.011_bb0030","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3109\/13625187.2011.591456","article-title":"Effective treatment of heavy and\/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomized, double-blind, placebo-controlled trials of oestradiol valerate and dienogest","volume":"16","author":"Fraser","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2011.11.011_bb0035","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/AOG.0b013e3181ec622b","article-title":"Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial","volume":"116","author":"Kaunitz","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.11.011_bb0040","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/AOG.0b013e3181f20177","article-title":"Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial","volume":"116","author":"Lukes","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.11.011_bb0045","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/00365516409060511","article-title":"Determination of menstrual blood loss","volume":"16","author":"Hallberg","year":"1964","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.contraception.2011.11.011_bb0050","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1471-0528.2005.00642.x","article-title":"Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts","volume":"112","author":"Reid","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2011.11.011_bb0055","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.contraception.2010.06.011","article-title":"Levonorgestrel-releasing intrauterine system compared to low-dose combined oral contraceptive pills for idiopathic menorrhagia: a randomized clinical trial","volume":"83","author":"Shabaan","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.11.011_bb0060","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0002-9378(71)90259-6","article-title":"Treatment of menorrhagia","volume":"110","author":"Nilsson","year":"1971","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.11.011_bb0065","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1185\/03007995.2010.526098","article-title":"Estimating a meaningful reduction in menstrual blood loss for women with heavy menstrual bleeding","volume":"26","author":"Lukes","year":"2010","journal-title":"Curr Med Res Opin"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411006718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411006718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T21:10:06Z","timestamp":1762117806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782411006718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0010782411006718"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2011.11.011","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate\/dienogest","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2011.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}